FOLH1 and neoplasm: Mel@PSMA-R12-125I showed predominantly uptake in the liver, spleen, kidney, intestine, and tumor within the first 8 h p.i., but were rapidly cleared from all the tested organs at 24 h p.i., showing good biodegradability and rapid clearance.